Medication Abortion

Pre-treatment with mifepristone for pain management in first-trimester surgical abortion care, high patient and provider satisfaction with telemedicine contraceptive counseling, an update to the CDC’s recommendation on self-administered DMPA-SC, and more.

Honest answers—supported by facts and research—and patient resources too!

Public health benefits of widespread HPV vaccination, potential for IUDs to be placed as emergency contraception 6-14 days after unprotected vaginal sex, etonogestrel implants to help with pelvic pain, and more.

Importance of trans-inclusive clinics and accessible education on evidence-based self-managed abortion techniques for gender-expansive individuals, an update to the CDC’s treatment guidelines for gonococcal infection, the effects of stigma and barriers to access on abortion method preference, and more.

Comparable effectiveness of Levonorgestrel and copper IUDs as emergency contraception, use of the Natural Cycles app for fertility awareness contraceptive method, transcutaneous electrical nerve stimulation as highly effective pain management in medication abortion care, and more.

Benefits of self-administered DMPA injections, an analysis of prophylactic pain management in medication abortion care, a need for ongoing education for providers on clinical indications for pelvic exams, the potential use of mifepristone as emergency contraception, and more.

Guidance for providers on medication abortion provision up to 70 days gestation, the need for expanded access to the most effective forms of emergency contraception, the important role partner treatment can play in the treatment of bacterial vaginosis, and more.

Society of Family Planning’s clinical recommendations for contraceptive counseling for transgender and gender-expansive patients, the positive effect of levonorgestrel IUDs on female sexual function, barriers to abortion care within religious hospital systems, and more.